Skip to main content

Ayurvedic medicine to treat diabetes

A pilot project on treatment of diabetes in one district each in Rajasthan, Gujarat and Bihar is successfully being implemented

Related Category:

Central Council for Research in Ayurvedic Sciences (CCRAS) in collaboration with Directorate General of Health Services, Ministry of Health & Family Welfare has implemented a programme viz. Integration of AYUSH (Ayurveda) component with National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases & Stroke (NPCDCS) programme in the identified districts of three states viz. Bhilwara (Rajasthan), Surendranagar (Gujarat) and Gaya (Bihar) to cater healthcare services and reduce the burden of non-communicable disease (NCDs) by combining the strength of Ayurveda and Yoga, Minister of State (Independent Charge) for AYUSH, Shripad Yesso Naik informed the Rajya Sabha, the upper house of Indian Parliament on Tuesday.

The programme was launched in January 2016 in two districts Bhilwara and Surendranagar, and in Gaya the programme was launched in April 2016.           

The programme is successfully functional in 52 centers - 49 community health centres (CHCs) and three district hospitals - all three identified districts. Till December 2017, 241,886 patients have been screened for selected non communicable disease, out of which 54,991 patients have been enrolled for selected NCDs under this programme and out of which 23,699 diabetic patients have been enrolled and given treatment, dietary regimen and Yoga classes, Naik said.

CCRAS has developed an anti-diabetic formulation namely AYUSH-82 and commercialised to several pharmaceutical companies through National Research Development Corporation (NRDC), New Delhi.

Council of Scientific & Industrial Research (CSIR), has developed a formulation - BGR34, after standardisation and pre-clinical studies conducted jointly by CSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP) and CSIR-National Botanical Research Institute (CSIR-NBRI), which is meant to be used by patients of newly diagnosed diabetes only as a measure of management of the disease, the Minister added.

1 Votes with an average with 5

Related Story

MCFL’s profit crosses Rs 200 crore in FY18

Mangalore Chemicals & Fertilizers Limited (MCFL), Karnataka’s largest fertiliser manufacturing unit, has reported the audited financial results for the quarter and year ended on March 31, 2018…

India’s organic consumption share less than 1%: Study

Despite the promising performance in terms of exports, the local consumption of organic produce is still at a nascent stage with a market share of less than 1 percent and per capita consumption at…